Nifty

:

17094.35

Sensex

:

57426.92

276.25 (1.64%)
1016.96 (1.80%)

Login

Nifty
Sensex

:
:

17094.35
57426.92

276.25 (1.64%)
1016.96 (1.80%)

Venus Remedies Ltd.

Pharmaceuticals & Drugs

Rating :

34/99

BSE: 526953 | NSE: VENUSREM

Watchlist

NSE BSE

205.15

30-Sep-2022

Day's Open
Day's High
Day's Low
Previous Close

204.15
208.20
204.15
203.90

Volume
Traded Value (lacs)
52 Week High
52 Week Low

26499
54.74
585.55
177.60

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

275.96
7.70
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

268.41
N/A
0.62

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

2.48
9.96
20.83

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-6.38
9.49
8.76

PAT CAGR (%)

10 Years
5 Years
3 Years

-3.36
-
-

P:E (Median)

8 Years
5 Years
3 Years

8.42
4.77
6.35

P:BV (Average)

8 Years
5 Years
3 Years

0.43
0.49
0.70

EV:EBITDA (Average)

8 Years
5 Years
3 Years

6.65
7.61
7.73

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var% Sep 21 Sep 20 Var%
Net Sales 154.93 136.85 13.21% 128.25 102.44 25.20% 117.44 114.07 2.95% 192.64 118.41 62.69%
Expenses 136.68 117.50 16.32% 120.95 94.57 27.89% 103.21 101.03 2.16% 164.71 113.25 45.44%
EBITDA 18.25 19.35 -5.68% 7.30 7.87 -7.24% 14.23 13.04 9.13% 27.93 5.16 441.28%
EBIDTM 11.78% 14.14% 5.69% 7.68% 12.11% 11.43% 14.50% 4.36%
Other Income 1.41 1.92 -26.56% 2.48 3.36 -26.19% 1.07 1.15 -6.96% 2.96 11.74 -74.79%
Interest 0.00 0.00 0 0.00 0.87 -100.00% 0.00 1.73 -100.00% 0.00 7.33 -100.00%
Depreciation 7.57 8.36 -9.45% 7.35 9.18 -19.93% 8.40 8.42 -0.24% 8.46 8.35 1.32%
PBT 12.09 12.91 -6.35% 2.42 21.74 -88.87% 6.90 8.50 -18.82% 22.44 8.82 154.42%
Tax 1.00 -1.68 - 0.00 -16.91 - -0.95 2.21 - -1.69 1.49 -
PAT 11.09 14.59 -23.99% 2.42 38.65 -93.74% 7.85 6.29 24.80% 24.13 7.33 229.20%
PATM 7.16% 10.66% 1.89% 37.73% 6.68% 5.52% 12.52% 6.19%
EPS 8.28 10.89 -23.97% 1.81 28.84 -93.72% 5.86 4.70 24.68% 18.01 5.47 229.25%

Description Jun 22 Jun 21 Var% Mar 22 Mar 21 Var% Dec 21 Dec 20 Var% Sep 21 Sep 20 Var%
Net Sales 143.08 129.81 10.22% 141.94 111.37 27.45% 124.34 121.94 1.97% 202.56 126.07 60.67%
Expenses 128.57 112.99 13.79% 136.39 106.88 27.61% 111.91 103.86 7.75% 175.26 115.42 51.85%
EBITDA 14.51 16.82 -13.73% 5.54 4.50 23.11% 12.44 18.08 -31.19% 27.30 10.65 156.34%
EBIDTM 10.14% 12.96% 3.91% 4.04% 10.00% 14.83% 13.48% 8.45%
Other Income 1.44 1.96 -26.53% 2.25 3.49 -35.53% 1.22 1.83 -33.33% 2.89 12.28 -76.47%
Interest 0.26 0.14 85.71% 0.00 0.96 -100.00% 0.31 1.81 -82.87% 0.03 7.39 -99.59%
Depreciation 7.80 8.62 -9.51% 7.56 9.38 -19.40% 8.64 8.70 -0.69% 8.71 8.61 1.16%
PBT 7.89 10.02 -21.26% 0.23 18.20 -98.74% 4.70 13.86 -66.09% 21.46 14.52 47.80%
Tax 1.00 -1.68 - 0.00 -16.91 - -0.95 2.21 - -1.69 1.49 -
PAT 6.89 11.70 -41.11% 0.23 35.11 -99.34% 5.65 11.65 -51.50% 23.15 13.03 77.67%
PATM 4.82% 9.01% 0.16% 31.53% 4.54% 9.56% 11.43% 10.33%
EPS 5.15 8.75 -41.14% 0.17 28.45 -99.40% 4.22 9.44 -55.30% 17.32 10.55 64.17%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 593.26 575.18 514.62 320.23 301.84 355.07 375.45 402.69 451.88 526.06 461.34 Net Sales Growth 25.75% 11.77% 60.70% 6.09% -14.99% -5.43% -6.76% -10.89% -14.10% 14.03% Cost Of Goods Sold 386.51 375.97 336.68 176.81 181.78 205.42 186.69 194.64 213.05 298.96 263.27 Gross Profit 206.75 199.22 177.94 143.42 120.06 149.65 188.76 208.05 238.82 227.10 198.07 GP Margin 34.85% 34.64% 34.58% 44.79% 39.78% 42.15% 50.28% 51.67% 52.85% 43.17% 42.93% Total Expenditure 525.55 506.36 467.76 277.16 267.55 311.51 328.16 323.14 364.94 392.83 342.85 Power & Fuel Cost - 3.78 3.39 3.41 3.50 3.02 3.08 2.90 3.28 3.11 2.86 % Of Sales - 0.66% 0.66% 1.06% 1.16% 0.85% 0.82% 0.72% 0.73% 0.59% 0.62% Employee Cost - 43.75 35.89 33.79 30.26 27.82 25.02 25.02 27.26 25.57 23.24 % Of Sales - 7.61% 6.97% 10.55% 10.03% 7.84% 6.66% 6.21% 6.03% 4.86% 5.04% Manufacturing Exp. - 25.48 20.63 18.35 18.98 34.28 75.01 58.94 73.60 20.75 19.72 % Of Sales - 4.43% 4.01% 5.73% 6.29% 9.65% 19.98% 14.64% 16.29% 3.94% 4.27% General & Admin Exp. - 15.01 13.76 15.22 9.79 11.86 12.20 10.85 14.36 13.81 11.10 % Of Sales - 2.61% 2.67% 4.75% 3.24% 3.34% 3.25% 2.69% 3.18% 2.63% 2.41% Selling & Distn. Exp. - 42.37 57.40 29.59 23.24 29.11 26.17 30.78 33.39 30.64 22.66 % Of Sales - 7.37% 11.15% 9.24% 7.70% 8.20% 6.97% 7.64% 7.39% 5.82% 4.91% Miscellaneous Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 22.66 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% EBITDA 67.71 68.82 46.86 43.07 34.29 43.56 47.29 79.55 86.94 133.23 118.49 EBITDA Margin 11.41% 11.96% 9.11% 13.45% 11.36% 12.27% 12.60% 19.75% 19.24% 25.33% 25.68% Other Income 7.92 8.43 17.76 3.58 4.51 1.19 3.10 0.67 0.55 0.41 0.39 Interest 0.00 0.00 12.73 13.05 25.15 35.44 35.87 36.74 40.70 29.29 24.45 Depreciation 31.78 32.58 34.28 31.05 32.95 32.73 39.32 40.47 44.74 38.61 31.76 PBT 43.85 44.67 17.62 2.55 -19.30 -23.42 -24.80 3.01 2.04 65.73 62.67 Tax -1.64 -4.32 -13.21 1.96 -1.15 3.16 -4.56 1.81 -2.51 4.78 5.53 Tax Rate -3.74% -9.67% -32.17% -31.31% 4.07% -13.49% 18.39% 60.13% -123.04% 7.27% 8.82% PAT 45.49 48.99 54.27 -8.23 -27.11 -26.58 -20.24 1.20 4.55 60.95 57.15 PAT before Minority Interest 45.49 48.99 54.27 -8.23 -27.11 -26.58 -20.24 1.20 4.55 60.95 57.15 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 7.67% 8.52% 10.55% -2.57% -8.98% -7.49% -5.39% 0.30% 1.01% 11.59% 12.39% PAT Growth -31.96% -9.73% - - - - - -73.63% -92.53% 6.65% EPS 33.95 36.56 40.50 -6.14 -20.23 -19.84 -15.10 0.90 3.40 45.49 42.65

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 611.92 598.65 548.12 339.33 321.89 372.41 400.04 418.27 463.99 541.56 468.64 Net Sales Growth 25.09% 9.22% 61.53% 5.42% -13.57% -6.91% -4.36% -9.85% -14.32% 15.56% Cost Of Goods Sold 392.26 385.45 340.79 174.31 181.95 205.08 227.07 238.51 268.94 300.00 262.26 Gross Profit 219.66 213.20 207.33 165.02 139.94 167.33 172.97 179.77 195.05 241.55 206.38 GP Margin 35.90% 35.61% 37.83% 48.63% 43.47% 44.93% 43.24% 42.98% 42.04% 44.60% 44.04% Total Expenditure 552.13 536.54 494.35 298.52 289.37 332.94 349.32 337.11 374.81 403.33 348.53 Power & Fuel Cost - 4.71 4.58 4.73 4.86 4.29 4.14 4.01 3.80 3.38 3.05 % Of Sales - 0.79% 0.84% 1.39% 1.51% 1.15% 1.03% 0.96% 0.82% 0.62% 0.65% Employee Cost - 52.33 46.02 46.02 42.10 39.31 34.27 32.44 32.36 30.45 27.30 % Of Sales - 8.74% 8.40% 13.56% 13.08% 10.56% 8.57% 7.76% 6.97% 5.62% 5.83% Manufacturing Exp. - 31.57 22.86 20.84 21.01 36.10 42.48 15.70 17.29 22.10 20.61 % Of Sales - 5.27% 4.17% 6.14% 6.53% 9.69% 10.62% 3.75% 3.73% 4.08% 4.40% General & Admin Exp. - 16.91 16.45 17.57 11.85 13.52 13.26 11.97 15.67 14.74 11.82 % Of Sales - 2.82% 3.00% 5.18% 3.68% 3.63% 3.31% 2.86% 3.38% 2.72% 2.52% Selling & Distn. Exp. - 45.56 63.64 35.05 27.60 34.65 28.10 34.48 36.75 32.65 23.50 % Of Sales - 7.61% 11.61% 10.33% 8.57% 9.30% 7.02% 8.24% 7.92% 6.03% 5.01% Miscellaneous Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 23.50 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% EBITDA 59.79 62.11 53.77 40.81 32.52 39.47 50.72 81.16 89.18 138.23 120.11 EBITDA Margin 9.77% 10.38% 9.81% 12.03% 10.10% 10.60% 12.68% 19.40% 19.22% 25.52% 25.63% Other Income 7.80 8.31 19.63 5.31 6.09 2.39 4.28 2.01 0.68 0.47 0.44 Interest 0.60 0.48 13.02 13.34 25.41 35.56 36.38 37.98 41.21 29.40 24.63 Depreciation 32.71 33.53 35.28 32.01 33.98 33.83 40.26 41.68 46.00 40.22 33.08 PBT 34.28 36.41 25.11 0.78 -20.77 -27.53 -21.64 3.51 2.65 69.08 62.84 Tax -1.64 -4.32 -13.21 1.96 -1.15 3.16 -4.56 1.81 -2.51 4.78 5.53 Tax Rate -4.78% -11.86% -27.21% -24.41% 3.87% -11.48% 21.07% 51.57% -94.72% 6.92% 8.80% PAT 35.92 40.72 61.77 -10.00 -28.57 -30.69 -17.08 1.70 5.16 64.30 57.31 PAT before Minority Interest 35.92 40.72 61.77 -10.00 -28.57 -30.69 -17.08 1.70 5.16 64.30 57.31 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.87% 6.80% 11.27% -2.95% -8.88% -8.24% -4.27% 0.41% 1.11% 11.87% 12.23% PAT Growth -49.76% -34.08% - - - - - -67.05% -91.98% 12.20% EPS 26.81 30.39 46.10 -7.46 -21.32 -22.90 -12.75 1.27 3.85 47.99 42.77

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 449.41 400.18 332.25 340.95 367.99 394.23 444.43 466.24 467.42 392.24 Share Capital 13.37 12.34 12.34 12.34 12.34 12.34 11.44 11.44 11.44 10.54 Total Reserves 436.05 374.09 319.91 328.61 355.65 381.89 432.99 454.79 455.97 376.92 Non-Current Liabilities 45.95 58.81 96.03 136.75 157.89 179.52 212.03 221.50 161.27 147.18 Secured Loans 0.00 0.00 23.92 60.88 86.02 112.69 134.55 150.91 114.28 103.89 Unsecured Loans 38.68 47.52 48.34 55.20 50.84 49.13 56.47 51.34 25.22 25.22 Long Term Provisions 7.95 7.38 6.63 5.32 4.50 4.29 3.79 3.78 3.31 2.91 Current Liabilities 82.61 87.82 215.98 254.46 222.61 193.71 177.59 157.06 207.33 190.06 Trade Payables 49.63 68.36 33.96 33.41 27.19 30.56 23.90 25.76 28.14 17.87 Other Current Liabilities 32.23 18.78 99.99 107.61 76.87 45.70 36.63 13.99 54.12 57.88 Short Term Borrowings 0.00 0.00 81.42 108.92 117.23 115.70 115.09 115.40 110.08 95.68 Short Term Provisions 0.75 0.68 0.61 4.52 1.32 1.76 1.97 1.91 14.99 18.63 Total Liabilities 577.97 546.81 644.26 732.16 748.49 767.46 834.05 844.80 836.02 729.48 Net Block 224.67 244.20 271.47 346.89 369.93 389.38 433.52 425.77 416.09 380.92 Gross Block 578.19 581.73 589.77 674.06 669.01 655.78 660.61 612.50 555.61 481.83 Accumulated Depreciation 353.52 337.53 318.30 327.17 299.08 266.40 227.09 186.73 139.52 100.91 Non Current Assets 313.57 333.08 360.33 478.57 499.96 517.54 575.53 618.72 567.61 500.20 Capital Work in Progress 25.23 25.11 24.63 64.76 64.76 66.25 80.37 78.30 67.80 47.81 Non Current Investment 0.14 0.14 0.14 0.14 0.14 28.74 28.74 28.74 28.74 28.74 Long Term Loans & Adv. 61.96 62.34 64.08 66.78 65.13 33.17 32.90 85.91 54.98 42.74 Other Non Current Assets 1.57 1.29 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 264.41 213.74 283.94 253.59 248.53 249.93 258.53 226.08 268.41 229.28 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 125.63 119.69 136.44 140.94 135.98 139.69 137.69 140.44 141.46 126.40 Sundry Debtors 30.41 16.44 29.78 31.39 44.15 41.91 53.88 59.37 62.80 53.11 Cash & Bank 49.97 30.24 1.44 1.28 3.64 3.15 3.04 3.52 4.38 6.26 Other Current Assets 58.40 5.70 55.72 5.15 64.77 65.18 63.91 22.76 59.77 43.51 Short Term Loans & Adv. 53.39 41.66 60.56 74.83 59.93 65.18 63.91 22.76 59.77 43.51 Net Current Assets 181.80 125.92 67.96 -0.87 25.93 56.22 80.94 69.02 61.08 39.21 Total Assets 577.98 546.82 644.27 732.16 748.49 767.47 834.06 844.80 836.02 729.48

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 440.45 400.28 323.37 332.52 361.91 388.67 437.62 456.68 461.61 379.13 Share Capital 13.37 12.34 12.34 12.34 12.34 12.34 11.44 11.44 11.44 10.54 Total Reserves 427.08 374.19 311.03 320.18 349.57 376.33 426.18 445.24 450.17 363.81 Non-Current Liabilities 45.95 58.12 95.82 136.68 158.47 179.52 212.05 221.55 161.75 147.18 Secured Loans 0.00 0.09 24.19 61.29 86.60 112.69 134.57 150.95 114.76 103.89 Unsecured Loans 38.68 46.74 47.87 54.73 50.84 49.13 56.47 51.34 25.22 25.22 Long Term Provisions 7.95 7.38 6.63 5.32 4.50 4.29 3.79 3.78 3.31 2.91 Current Liabilities 92.74 97.45 224.58 263.62 230.38 196.81 193.14 162.83 210.99 191.25 Trade Payables 54.29 71.36 36.70 36.00 29.33 29.73 25.14 29.56 31.22 18.76 Other Current Liabilities 33.64 21.10 101.70 110.30 78.47 46.16 42.71 15.96 54.70 58.18 Short Term Borrowings 4.06 4.30 85.58 112.80 121.26 119.16 123.32 115.40 110.08 95.68 Short Term Provisions 0.75 0.68 0.61 4.52 1.32 1.76 1.97 1.91 14.99 18.63 Total Liabilities 579.14 555.85 643.77 732.82 750.76 765.00 842.81 841.06 834.35 717.56 Net Block 240.94 261.68 289.37 364.45 389.20 406.18 452.48 443.65 439.46 401.42 Gross Block 612.50 616.32 623.96 707.02 702.77 686.50 679.57 641.12 587.38 511.00 Accumulated Depreciation 371.57 354.63 334.59 342.57 313.57 280.32 227.09 197.47 147.93 109.58 Non Current Assets 301.10 321.82 349.77 467.39 490.50 505.60 565.75 607.85 562.24 491.97 Capital Work in Progress 25.23 25.11 24.63 64.76 64.76 66.25 80.37 78.30 67.80 47.81 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 34.93 35.03 35.77 38.18 36.53 33.17 32.90 85.91 54.98 42.74 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 278.04 234.03 294.00 265.43 260.27 259.41 277.07 233.21 272.11 225.58 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 125.64 119.99 141.12 142.73 138.17 140.60 143.29 142.87 142.26 128.03 Sundry Debtors 38.60 32.04 30.69 38.04 47.27 47.29 61.59 63.22 64.99 47.11 Cash & Bank 50.40 31.42 2.13 2.81 3.98 3.56 7.07 3.62 4.41 6.36 Other Current Assets 63.40 5.70 55.72 5.15 70.84 67.96 65.12 23.51 60.47 44.08 Short Term Loans & Adv. 58.39 44.88 64.34 76.70 66.00 67.96 65.12 23.51 60.47 44.08 Net Current Assets 185.30 136.59 69.43 1.81 29.88 62.59 83.93 70.38 61.12 34.33 Total Assets 579.14 555.85 643.77 732.82 750.77 765.01 842.82 841.06 834.35 717.55

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 40.90 132.34 77.75 43.65 51.58 61.77 41.91 66.76 52.56 50.66 PBT 44.67 17.62 2.55 -19.30 -23.42 -24.80 3.01 2.04 65.73 62.67 Adjustment 24.83 21.59 40.39 59.20 64.73 69.30 53.72 81.90 35.95 39.38 Changes in Working Capital -28.60 69.69 20.37 3.75 10.27 17.27 -14.82 -17.18 -49.12 -51.39 Cash after chg. in Working capital 40.90 108.89 63.31 43.65 51.58 61.77 41.91 66.76 52.56 50.66 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 23.44 14.44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -16.65 55.98 -4.64 -11.27 -11.48 -18.06 3.20 -67.15 -93.75 -102.47 Net Fixed Assets 3.42 7.56 124.42 -5.05 -11.74 18.95 -50.18 -67.39 -93.77 -101.63 Net Investments 0.00 0.00 0.00 0.00 28.60 0.00 0.00 0.00 0.00 0.00 Others -20.07 48.42 -129.06 -6.22 -28.34 -37.01 53.38 0.24 0.02 -0.84 Cash from Financing Activity -9.13 -161.88 -72.35 -34.74 -39.61 -43.60 -45.59 -0.47 39.31 55.15 Net Cash Inflow / Outflow 15.12 26.45 0.76 -2.36 0.49 0.11 -0.48 -0.86 -1.88 3.35 Opening Cash & Equivalents 27.70 0.00 0.50 3.64 3.15 3.04 3.52 4.38 6.26 2.91 Closing Cash & Equivalent 42.83 26.45 1.26 1.28 3.64 3.15 3.04 3.52 4.38 6.26

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 41.00 131.84 77.60 45.33 31.19 58.93 46.88 67.80 52.65 52.15 PBT 36.41 25.11 0.78 -20.77 -27.53 -21.64 3.51 2.65 69.08 62.84 Adjustment 26.33 21.89 41.56 60.72 66.24 70.61 56.41 83.56 37.21 40.72 Changes in Working Capital -21.74 61.39 20.82 5.37 -7.52 9.96 -13.04 -18.40 -53.65 -51.41 Cash after chg. in Working capital 41.00 108.39 63.16 45.33 31.19 58.93 46.88 67.80 52.65 52.15 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 23.44 14.44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -16.63 56.49 -4.75 -11.33 -11.48 -18.32 2.92 -67.18 -94.66 -103.89 Net Fixed Assets 3.42 7.56 124.42 -5.05 -11.74 18.95 -50.18 -67.39 -93.77 -101.63 Net Investments 0.00 0.00 0.00 0.00 28.60 0.00 0.00 0.00 0.00 0.00 Others -20.05 48.93 -129.17 -6.28 -28.34 -37.27 53.10 0.21 -0.89 -2.26 Cash from Financing Activity -9.48 -162.24 -73.00 -35.17 -39.23 -44.13 -46.35 -1.42 40.06 55.15 Net Cash Inflow / Outflow 14.90 26.09 -0.15 -1.17 -19.52 -3.51 3.46 -0.79 -1.95 3.41 Opening Cash & Equivalents 28.88 1.94 2.03 3.98 0.00 7.07 3.62 4.41 6.36 2.95 Closing Cash & Equivalent 43.26 28.88 1.94 2.81 -19.52 3.56 7.07 3.62 4.41 6.36

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 336.21 313.10 269.21 276.25 298.16 319.42 388.42 407.48 408.51 367.54 ROA 8.71% 9.11% -1.20% -3.66% -3.51% -2.53% 0.14% 0.54% 7.79% 8.68% ROE 11.72% 15.10% -2.44% -7.65% -6.98% -4.83% 0.26% 0.97% 14.26% 16.38% ROCE 9.55% 10.80% 1.15% -0.48% 1.75% 1.50% 5.11% 5.55% 13.40% 14.49% Fixed Asset Turnover 0.99 0.88 0.51 0.45 0.54 0.57 0.63 0.77 1.02 1.04 Receivable days 14.87 16.39 34.86 45.68 44.23 46.56 51.33 49.34 40.15 38.45 Inventory Days 77.84 90.83 158.08 167.43 141.69 134.83 126.05 113.85 92.77 87.83 Payable days 57.28 55.46 42.49 37.63 31.43 27.90 25.33 24.89 20.07 14.84 Cash Conversion Cycle 35.43 51.76 150.45 175.48 154.49 153.50 152.04 138.30 112.85 111.44 Total Debt/Equity 0.09 0.12 0.65 0.86 0.82 0.78 0.74 0.68 0.62 0.70 Interest Cover 0.00 4.23 0.52 -0.12 0.34 0.31 1.08 1.05 3.24 3.56

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 329.50 313.18 262.01 269.42 293.23 314.92 382.47 399.13 403.43 355.10 ROA 7.18% 10.30% -1.45% -3.85% -4.05% -2.12% 0.20% 0.62% 8.29% 8.87% ROE 9.85% 17.40% -3.05% -8.23% -8.18% -4.13% 0.38% 1.12% 15.38% 17.04% ROCE 7.89% 12.37% 0.90% -0.67% 1.17% 2.00% 5.35% 5.74% 14.06% 14.85% Fixed Asset Turnover 0.97 0.88 0.51 0.46 0.54 0.59 0.63 0.76 0.99 1.00 Receivable days 21.54 20.89 36.97 48.37 46.34 49.67 54.45 50.42 37.72 33.88 Inventory Days 74.88 86.94 152.66 159.26 136.61 129.51 124.86 112.15 90.94 87.34 Payable days 59.49 57.86 42.82 37.91 30.30 26.74 26.74 27.25 21.28 15.09 Cash Conversion Cycle 36.93 49.96 146.80 169.72 152.65 152.44 152.57 135.32 107.37 106.14 Total Debt/Equity 0.10 0.13 0.68 0.90 0.85 0.80 0.77 0.70 0.63 0.72 Interest Cover 76.69 4.73 0.40 -0.17 0.23 0.41 1.09 1.06 3.35 3.55

Top Investors:

Annual Reports:

News Update:

Venus Remedies - Quarterly Results
30th Jul 2022, 19:05 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback